ESRRA and breast carcinoma: Furthermore, there seemed to be an inverse association between the miR-137 level and the ERRα expression in the breast cancer cell line we tested, which suggests that the silencing of miR-137 in tumor cells, especially in breast cancer, may be involved in the dysregulation of ERRα and contributed to breast tumorigenesis.